Chlamydia pneumoniae and Atherosclerosis following Carotid Endarterectomy
暂无分享,去创建一个
B. Jahromi | M. Hill | S. Hutchison | K. Holmes | B. Chiu | W. Tucker
[1] J. Falck,et al. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. , 2002, American journal of physiology. Heart and circulatory physiology.
[2] R. Peeling,et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] T. DeGraba,et al. Presence of Chlamydia pneumoniae in Human Symptomatic and Asymptomatic Carotid Atherosclerotic Plaque , 2001, Stroke.
[4] P. Roholl,et al. Distribution of Chlamydia pneumoniae in the Human Arterial System and Its Relation to the Local Amount of Atherosclerosis Within the Individual , 2001, Circulation.
[5] B. Conrad,et al. Enhanced Progression of Early Carotid Atherosclerosis Is Related to Chlamydia pneumoniae (Taiwan Acute Respiratory) Seropositivity , 2001, Circulation.
[6] I. Konishi,et al. An association between an antibody against Chlamydia pneumoniae and common carotid atherosclerosis. , 2001, Internal medicine.
[7] M. G. Cusi,et al. Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries. , 2001, Journal of medical microbiology.
[8] Werner Poewe,et al. Chronic Infections and the Risk of Carotid Atherosclerosis: Prospective Results From a Large Population Study , 2001, Circulation.
[9] G. Stanek,et al. Multicenter Comparison Trial of DNA Extraction Methods and PCR Assays for Detection of Chlamydia pneumoniae in Endarterectomy Specimens , 2001, Journal of Clinical Microbiology.
[10] B. Horne,et al. Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death , 2001, Circulation.
[11] P. Roholl,et al. Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions , 2000, Journal of clinical pathology.
[12] A. Davies,et al. Chlamydia pneumoniae Does Not Influence Atherosclerotic Plaque Behavior in Patients With Established Carotid Artery Stenosis , 2000, Stroke.
[13] A. Busjahn,et al. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. , 2000, The Journal of laboratory and clinical medicine.
[14] C. Zoccali,et al. Inflammation is associated with carotid atherosclerosis in dialysis patients , 2000, Journal of hypertension.
[15] S. Blankenberg,et al. Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? , 2000, Stroke.
[16] R. Sacco,et al. Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study. , 2000, Stroke.
[17] B. Fagerberg,et al. Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness. , 2000, Stroke.
[18] P. Apfalter,et al. Isolation and Continuous Growth of Chlamydia pneumoniae from Arterectomy Specimens , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[19] A. Plant,et al. Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. , 1999, The American journal of cardiology.
[20] L. Weinehall,et al. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. , 1999, Stroke.
[21] H. Steinmetz,et al. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. , 1999, Circulation.
[22] F. Blasi,et al. Demonstration of Viable Chlamydia pneumoniae in Atherosclerotic Plaques of Carotid Arteries by Reverse Transcriptase Polymerase Chain Reaction , 1999, Annals of vascular surgery.
[23] B. Horne,et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. , 1999, Circulation.
[24] P. Apfalter,et al. Detection of Chlamydia pneumoniae DNA in atheromatous tissues by polymerase chain reaction. , 1999, Wiener klinische Wochenschrift.
[25] B. Fagerberg,et al. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. , 1999, Stroke.
[26] K. Dalhoff,et al. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. , 1998, Atherosclerosis.
[27] W. Solbach,et al. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients , 1998, Medical Microbiology and Immunology.
[28] M. Shirai,et al. Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery. , 1998, Stroke.
[29] G. Lip,et al. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. , 1998, Stroke.
[30] D. Paterson,et al. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients , 1998, Pathology.
[31] W. F. Jackson,et al. Characterization and function of Ca 2 1-activated K 1 channels in arteriolar muscle cells , 1997 .
[32] J Kievit,et al. Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. , 1998, Stroke.
[33] A. Camm,et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. , 1998, Circulation.
[34] I. Fong,et al. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.
[35] K. Burnand,et al. Recurrent carotid stenosis after carotid endarterectomy , 1997, The British journal of surgery.
[36] E. Gurfinkel,et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.
[37] M. Maass,et al. Endovascular Presence of Chlamydia pneumoniae in Patients with Hemodynamically Effective Carotid Artery Stenosis , 1997, Angiology.
[38] A. Lee,et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. , 1997, The Journal of infectious diseases.
[39] R. Schmidt,et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. , 1997, The American journal of pathology.
[40] P. Saikku,et al. Association of chlamydial infection with cerebrovascular disease. , 1996, Stroke.
[41] A. Coulson,et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. , 1995, Circulation.
[42] A. Folsom,et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.
[43] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[44] D. Strandness,et al. Carotid artery duplex scanning , 1987, Journal of clinical ultrasound : JCU.